Stéphane Thiroloix

Stéphane Thiroloix

Founder at
Algotherapeutix SAS
Health Technology
Producer Manufacturing
Consumer Services

Profile

Stéphane Thiroloix is the founder of AlgoTherapeutix SAS, serving as President, Chief Executive Officer & Director since 2018.
Current job includes Vice President-Business Development at Ipsen Pharma SA since 2009.
Former jobs include Director at DBV Technologies SA, Director-Business Development & Marketing at GlaxoSmithKline AG, Managing Director at Ipsen Pharma SAS, Vice President-Europe & General Manager-France at Bristol Myers Squibb Co., President-Europe ASD Division at Smith & Nephew plc, General Manager at Sanofi, Executive Vice President-Corporate Development at Ipsen SA, Vice President-Business Development at Ipsen International GmbH, and Member-Supervisory Board at Laboratoires Mayoly Spindler SAS. Education includes an undergraduate degree from École des Hautes Études Commerciales de Paris, conferred in 1986.

Stéphane Thiroloix active positions

CompaniesPositionStart
Corporate Officer/Principal -
Founder 01/01/2018

Former positions of Stéphane Thiroloix

CompaniesPositionEnd
SMITH & NEPHEW PLC Corporate Officer/Principal -
Director/Board Member -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
President -
Sales & Marketing -
See the detail of Stéphane Thiroloix's experience

Training of Stéphane Thiroloix

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Stéphane Thiroloix
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!